Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 4 studies | 20% ± 4% |
Insufficient scRNA-seq data for expression of DOHH at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 899.84 | 1445 / 1445 | 100% | 25.10 | 183 / 183 |
uterus | 100% | 788.74 | 170 / 170 | 100% | 32.19 | 458 / 459 |
thymus | 100% | 641.54 | 651 / 653 | 100% | 22.74 | 604 / 605 |
brain | 100% | 1723.36 | 2640 / 2642 | 100% | 31.82 | 702 / 705 |
liver | 100% | 539.86 | 225 / 226 | 100% | 18.68 | 405 / 406 |
prostate | 100% | 802.08 | 245 / 245 | 99% | 26.63 | 498 / 502 |
adrenal gland | 100% | 766.08 | 258 / 258 | 99% | 24.98 | 228 / 230 |
intestine | 100% | 817.77 | 966 / 966 | 99% | 29.23 | 522 / 527 |
ovary | 100% | 626.37 | 180 / 180 | 99% | 14.89 | 425 / 430 |
kidney | 100% | 906.35 | 89 / 89 | 99% | 20.64 | 890 / 901 |
skin | 100% | 1051.48 | 1808 / 1809 | 99% | 30.02 | 466 / 472 |
bladder | 100% | 888.62 | 21 / 21 | 98% | 30.05 | 494 / 504 |
pancreas | 99% | 438.82 | 324 / 328 | 99% | 23.00 | 176 / 178 |
stomach | 100% | 669.33 | 358 / 359 | 98% | 28.33 | 279 / 286 |
lung | 99% | 698.86 | 572 / 578 | 97% | 19.54 | 1115 / 1155 |
breast | 100% | 710.12 | 459 / 459 | 95% | 19.43 | 1057 / 1118 |
eye | 0% | 0 | 0 / 0 | 100% | 37.80 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 41.92 | 29 / 29 |
muscle | 100% | 1105.64 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 784.34 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 36.99 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 46.98 | 1 / 1 |
blood vessel | 100% | 698.10 | 1333 / 1335 | 0% | 0 | 0 / 0 |
adipose | 100% | 711.40 | 1202 / 1204 | 0% | 0 | 0 / 0 |
heart | 97% | 691.62 | 834 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 85% | 486.90 | 794 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0008612 | Biological process | peptidyl-lysine modification to peptidyl-hypusine |
GO_0005575 | Cellular component | cellular_component |
GO_0005829 | Cellular component | cytosol |
GO_0019135 | Molecular function | deoxyhypusine monooxygenase activity |
GO_0005506 | Molecular function | iron ion binding |
GO_0005515 | Molecular function | protein binding |
Gene name | DOHH |
Protein name | Deoxyhypusine hydroxylase Deoxyhypusine hydroxylase (hDOHH) (EC 1.14.99.29) (Deoxyhypusine dioxygenase) (Deoxyhypusine monooxygenase) (HEAT-like repeat-containing protein 1) |
Synonyms | HLRC1 |
Description | FUNCTION: Catalyzes the hydroxylation of the N(6)-(4-aminobutyl)-L-lysine intermediate produced by deoxyhypusine synthase/DHPS on a critical lysine of the eukaryotic translation initiation factor 5A/eIF-5A. This is the second step of the post-translational modification of that lysine into an unusual amino acid residue named hypusine . Hypusination is unique to mature eIF-5A factor and is essential for its function (By similarity). . |
Accessions | A0A5F9ZGM7 ENST00000427575.6 ENST00000671696.1 ENST00000672935.1 Q9BU89 |